# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-053165
Filing Date
2021-04-21
Accepted
2021-04-21 17:30:32
Documents
4
Period of Report
2021-06-07

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm2113403-1_def14a.htm | DEF 14A | 611646
2 | GRAPHIC | sg_richardjbastiani-bw.jpg | GRAPHIC | 9491
3 | GRAPHIC | tm2113403d1-proxy_01page4c.jpg | GRAPHIC | 1990708
4 | GRAPHIC | tm2113403d1-proxy_02page4c.jpg | GRAPHIC | 1625993
| Complete submission text file | 0001104659-21-053165.txt |  | 5598968

Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37544 | Film No.: 21842586
SIC: 2836 Biological Products, (No Diagnostic Substances)